
TrialSpark
TrialSpark acquires clinical-stage drugs and develops them using its proprietary tech-driven drug development platform.
$156M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
About TrialSpark
It aims to bring new treatments to patients faster and more efficiently. TrialSpark partners with pharma, universities, and biotech companies.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $156M | — | fundraisingfox.com |
Timeline
- Website created
Companies like TrialSpark
FFormation Bio$372M Series B+ · Jun 2024
NNoema PharmaSeries B+ · Nov 2025
CCellCentric$220M Series B+ · May 2026
AAmplio PharmaSeed · Oct 2026
AAnodyneSeries A · Jun 2026BBiossil$153M Seed · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/trialspark (get a free API key).